Skip to content

Clinical trials

End Stage Liver Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: End Stage Liver Disease Country / region: United States Clear all

65 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20021
20032
20041
20062
20072
20102
20116
20123
20131
20142
20151
20163
20172
20187
20193
20202
20214
202210
20232
20243
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Terminated11
Recruiting9
Unknown status4
Active, not recruiting4
Withdrawn2
Suspended2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic5
Massachusetts General Hospital4
Baylor Research Institute3
University of California, Los Angeles3
University of California, San Francisco3
University of Pennsylvania3
University of Washington3
Albert Einstein Healthcare Network2
Arbor Research Collaborative for Health2
Bridge to Life Ltd.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
End Stage Liver Disease65
Fibrosis15
Liver Cirrhosis9
Kidney Failure, Chronic7
Heart Failure6
Hepatitis C6
Sarcopenia6
Frailty5
Liver Diseases5
Pulmonary Disease, Chronic Obstructive5

Trials

Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.